(HealthDay)—Steroids reduce the risk for major adverse kidney outcomes in people with high-risk immunoglobulin A nephropathy (IgAN), but full-dose methylprednisolone increased the risk for serious adverse events, according ...
Nov 16, 2021
0
2
(HealthDay)—Nonsteroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen, do not increase blood pressure among postpartum women with hypertensive disorders of pregnancy, according to a study published online Nov. 4 ...
Nov 7, 2019
0
2
A drug used to treat gout, probenecid, may improve heart function in individuals with a particular heart defect, according to results from a small pilot study run by a University of Cincinnati researcher.
Aug 27, 2020
0
4
A low-cost version of ketamine to treat severe depression has performed strongly in a double-blind trial that compared it with placebo.
Jul 13, 2023
0
1
Two new studies have cast unprecedented light on disease processes in tuberculosis, identifying key genetic changes that cause damage in the lungs and a drug treatment that could speed up recovery.
Jun 15, 2021
0
12
Treatment with growth hormone-releasing hormone appears to be associated with favorable cognitive effects among both adults with mild cognitive impairment and healthy older adults, according to a randomized clinical trial ...
Aug 6, 2012
0
0
Patients who started estrogen over the age of 60 did not derive a mortality benefit and experienced more adverse effects particularly among those 70 and older, regardless of whether they had their ovaries removed.
Sep 10, 2019
1
7
A randomized controlled trial looked at in-vitro fertilization (IVF) outcomes in the UK and Hong Kong. The results, published in The Lancet, provide much-needed evidence that using time-lapse imaging (TLI) does not improve ...
Jul 18, 2024
0
23
(HealthDay)—For older adults, low-dose aspirin does not reduce the risk for depression, according to a study published online June 3 in JAMA Psychiatry.
Jun 4, 2020
0
4
A recent clinical trial found that the adult antiviral drug, tenofovir disoproxil fumarate (tenofovir DF), is safe and effective in treating adolescents with hepatitis B virus (HBV). Trial results published in the December ...
Dec 5, 2012
0
0
